Modulation Therapeutics is a brand that is dedicated to developing new therapies for defeating deadly cancers and related diseases. With a team of passionate pharmaceutical scientists, discoverers, researchers, biologists, chemists, and business developers, Modulation Therapeutics is committed to improving the quality of life for patients with the greatest needs. Founded in 2011 as a spinoff of The Moffitt Cancer Research Center, the company has since relocated to pursue research and development opportunities in West Virginia.

They now have three novel therapies targeting nine diseases. Their mission is to efficiently move their pipeline of targeted radiotherapy, small molecule, and peptide-based drug compounds through the clinic to achieve rapid FDA approval and patient access. Modulation Therapeutics is driven by their passion to make a difference in the lives of cancer patients and to bring hope where it is needed most